Myocardial Damage Early Detection by Novel Biochemical Markers
The spectrum of unstable coronary syndromes has been the object of steadily increasing research particularly in respect of novel diagnostic and treatment modalities. Although the WHO criteria for the diagnosis of acute myocardial infarction have been known for decades, there is still much debate as...
| Other Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Dordrecht
Springer Netherlands
1998, 1998
|
| Edition: | 1st ed. 1998 |
| Series: | Developments in Cardiovascular Medicine
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- 1. Cellular mechanisms of ischaemic myocardial damage
- 2. Creatine Kinase isoforms
- 3. Myocardial Damage: The role of Troponin T
- 4. Troponin I: structure, physiology and it’s role in risk stratification of angina patients
- 5. Myoglobin
- 6. Glycogen phosphorylase isoenzyme BB
- 7. Fatty acid-binding protein as a plasma marker for the early detection of myocardial injury
- 8. Mechanisms of protein release from injured heart muscle
- 9. Prolonged chest pain and the early detection of myocardial damage by novel biochemical markers — practical considerations
- 10. Prognostic value of biochemical markers in ischaemic heart disease
- 11. Troponin T in the management of ischaemic heart disease patients: a clinical cardiologist’s view
- 12. New soluble markers for assessment of infarct size
- 13. Value of soluble markers in the diagnosis of reperfusion after thrombolysis
- 14. The assessment of myocardial damage in heart transplantation
- 15. Economic aspects of new biochemical markers for the detection of myocardial damage
- 16. Role of serum biochemical markers in clinical trials
- 17. Pre-clinical application of markers of myocardial damage